These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8223212)

  • 21. Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agents.
    Rijken DC; Seifried E; Barrett-Bergshoeff MM; Dooijewaard G
    Thromb Haemost; 1990 Aug; 64(1):47-52. PubMed ID: 2125758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
    Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis.
    Lijnen HR; Stassen JM; Vanlinthout I; Fukao H; Okada K; Matsuo O; Collen D
    Thromb Haemost; 1991 Oct; 66(4):468-73. PubMed ID: 1796398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Laboratory control of fibrinolytic therapy].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):30-7. PubMed ID: 2427412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties.
    Härdig BM; Persson HW; Olsson SB
    Thromb Res; 2006; 117(6):713-20. PubMed ID: 15993473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forceful pulsatile local infusion of enzyme accelerates thrombolysis: in vivo evaluation of a new delivery system.
    Kandarpa K; Drinker PA; Singer SJ; Caramore D
    Radiology; 1988 Sep; 168(3):739-44. PubMed ID: 3406403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successes, failures and complications in thrombolytic therapy in peripheral, arterial and venous occlusions].
    Fischer M; Denck H; Olbert F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):938-45. PubMed ID: 94889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
    Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M
    Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood clot disruption in vitro using shockwaves delivered by an extracorporeal generator after pre-exposure to lytic agent.
    Goldenstedt C; Birer A; Cathignol D; Lafon C
    Ultrasound Med Biol; 2009 Jun; 35(6):985-90. PubMed ID: 19285784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
    Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS
    Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The theory and practice of streptokinase therapy].
    Dahlström H
    Z Gesamte Inn Med; 1965 Dec; 20(23):709-12. PubMed ID: 5872320
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Report of experiences with fibrinolytic therapy of deep venous thrombosis of the legs].
    Schweder R; Ebert G; Rinke W; Ketterer KP
    Anaesthesiol Reanim; 1990; 15(2):81-5. PubMed ID: 2340058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Formation of streptokinase-heparin complexes and their properties].
    Nikandrov VN; Votiakov VI; Naumovich SA; Vorob'eva GV; Tsymanovich SG
    Vopr Med Khim; 1987; 33(2):54-8. PubMed ID: 3604141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspects of thrombelytic therapy using streptokinase].
    Vogel G; Huyke R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):456-67. PubMed ID: 63433
    [No Abstract]   [Full Text] [Related]  

  • 38. [Streptodecase-2 in the treatment of acute myocardial infarct, unstable stenocardia, thromboembolism and thrombosis].
    Butorov VN; Repinskaia NP; Demidova AV; Sysoeva NA; Kirichenko AA
    Ter Arkh; 1990; 62(8):21-6. PubMed ID: 2274864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport processes in fibrinolysis and fibrinolytic therapy.
    Blinc A; Francis CW
    Thromb Haemost; 1996 Oct; 76(4):481-91. PubMed ID: 8902982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.